SCPX
Scorpius Holdings Inc.

1
Loading...
Loading...
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in San Antonio, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
90

Frequently Asked Questions

What is Market Cap of Scorpius Holdings Inc.?
What is the 52-week high for Scorpius Holdings Inc.?
What is the 52-week low for Scorpius Holdings Inc.?
What is Scorpius Holdings Inc. stock price today?
What was Scorpius Holdings Inc. stock price yesterday?
What is the PE ratio of Scorpius Holdings Inc.?
What is the Price-to-Book ratio of Scorpius Holdings Inc.?
What is the 50-day moving average of Scorpius Holdings Inc.?
How many employess does Scorpius Holdings Inc. has?

Latest SCPX News

View
No SCPX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.